HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

House Sunscreen Bill Advances, But TEA Review Deadlines In Question

This article was originally published in The Rose Sheet

Executive Summary

The House Energy and Commerce Health subcommittee unanimously advanced the Sunscreen Innovation Act to full committee June 19, but provisions in the original bill seeking a tight timeline for FDA’s review of sunscreen ingredient time-and-extent applications are now in limbo, according to the Public Access to Sunscreens coalition of stakeholders.

You may also be interested in...



Sunscreen Bill Would Expedite TEA Decisions, Set Deadlines

The Sunscreen Innovation Act, introduced in both the House and the Senate, would streamline the process for FDA review of sunscreen TEAs and impose deadlines for agency action.

US And Trading Neighbors Advocate Risk-Based, Science-Backed Cosmetics Regs

As European industry’s concerns grow about “politicization” of regulatory programs, the United States-Mexico-Canada Agreement’s cosmetics annex directs regulatory authorities pursuing new rules to give due consideration to scientific and technical guidance documents developed through international collaboration.

Ease Of Reaching Canada With Cosmetic/Drug Interface Products To Improve Under USMCA

Canada has agreed to end its practice of quarantining and retesting certain cosmetic-OTC drug products from the US, as part of a cosmetics-specific annex to the United States-Mexico-Canada Agreement. “There will be a very significant and immediate benefit to US exporters of OTC products to Canada,” a Personal Care Products Council exec said.

Related Companies

UsernamePublicRestriction

Register

RS019090

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel